Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 516

2.

[The concept of supersensitivity psychosis. The particular case of clozapine].

Llorca PM, Penault F, Lançon C, Dufumier E, Vaiva G.

Encephale. 1999 Nov-Dec;25(6):638-44. French.

PMID:
10668609
3.
4.

[Clozapine withdrawal. A review].

Szafrański T, Gmurkowski K.

Psychiatr Pol. 1999 Jan-Feb;33(1):51-67. Review. Polish.

PMID:
10786215
5.

Supersensitivity psychosis in a case with clozapine tolerance.

Ozcan S, Soydan A, Tamam L.

Eur Rev Med Pharmacol Sci. 2012 Oct;16 Suppl 4:70-3.

PMID:
23090814
6.

Cholinergic rebound and rapid onset psychosis following abrupt clozapine withdrawal.

Shiovitz TM, Welke TL, Tigel PD, Anand R, Hartman RD, Sramek JJ, Kurtz NM, Cutler NR.

Schizophr Bull. 1996;22(4):591-5.

PMID:
8938913
7.

Clozapine withdrawal resulting in delirium with psychosis: a report of three cases.

Stanilla JK, de Leon J, Simpson GM.

J Clin Psychiatry. 1997 Jun;58(6):252-5. Review.

PMID:
9228890
8.

Clozapine-withdrawal catatonia.

Bastiampillai T, Forooziya F, Dhillon R.

Aust N Z J Psychiatry. 2009 Mar;43(3):283-4. No abstract available.

PMID:
19230235
9.

The evaluation and treatment of first-episode psychosis.

Sheitman BB, Lee H, Strous R, Lieberman JA.

Schizophr Bull. 1997;23(4):653-61. Review. Erratum in: Schizophr Bull. 2006 Apr;32(2):401. Strauss, R [corrected to Strous, R].

PMID:
9366001
10.

The concept of supersensitivity psychosis.

Kirkpatrick B, Alphs L, Buchanan RW.

J Nerv Ment Dis. 1992 Apr;180(4):265-70. Review.

PMID:
1348269
11.

Atypical antipsychotics: CATIE study, drug-induced movement disorder and resulting iatrogenic psychiatric-like symptoms, supersensitivity rebound psychosis and withdrawal discontinuation syndromes.

Chouinard G, Chouinard VA.

Psychother Psychosom. 2008;77(2):69-77. doi: 10.1159/000112883. Epub 2008 Jan 25. No abstract available.

PMID:
18230939
12.

[Iatrogenic psychiatric-like symptoms recognition].

Demily C, Chouinard VA, Chouinard G.

Encephale. 2010 Oct;36(5):417-24. doi: 10.1016/j.encep.2010.01.003. Epub 2010 Mar 6. Review. French.

PMID:
21035632
13.

Rebound psychosis: effect of discontinuation of antipsychotics in Parkinson's disease.

Fernandez HH, Trieschmann ME, Okun MS.

Mov Disord. 2005 Jan;20(1):104-5.

PMID:
15390047
14.

[Value of clozapine in treatment of psychotic disorder in Parkinson disease].

Abbar M, Courtet P, Castelnau D.

Encephale. 1996 Jan-Feb;22(1):53-63. Review. French.

PMID:
8681876
15.

Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment.

Viguera AC, Baldessarini RJ, Hegarty JD, van Kammen DP, Tohen M.

Arch Gen Psychiatry. 1997 Jan;54(1):49-55.

PMID:
9006400
16.

Neuroleptic withdrawal psychosis in Tourette's disorder.

Silva RR, Friedhoff AJ, Alpert M.

Biol Psychiatry. 1993 Sep 1;34(5):341-2. No abstract available.

PMID:
8104510
17.

Clozapine as a drug of dependence.

Goudie AJ, Smith JA, Robertson A, Cavanagh C.

Psychopharmacology (Berl). 1999 Mar;142(4):369-74.

PMID:
10229061
18.

Supersensitivity psychosis in patients with schizophrenia after sudden olanzapine withdrawal.

Llorca PM, Vaiva G, Lancon C.

Can J Psychiatry. 2001 Feb;46(1):87-8. No abstract available.

PMID:
11221497
19.

More data on supersensitivity psychosis.

Witschy JK, Malone GL, Holden LD.

Am J Psychiatry. 1984 Oct;141(10):1302. No abstract available.

PMID:
6148896
20.

[The risk of neuroleptic discontinuation in schizophrenia].

Jarema M.

Psychiatr Pol. 1999 Jan-Feb;33(1):69-81. Review. Polish.

PMID:
10786216

Supplemental Content

Support Center